{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:17:42Z","timestamp":1794007062710,"version":"4.8.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.humimm.2024.111229","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T23:47:56Z","timestamp":1736552876000},"page":"111229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies"],"prefix":"10.1016","volume":"86","author":[{"given":"Rezvan","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia Motlagh","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina Janbaz","family":"Alamdary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Kamrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Sadegh","family":"Soltani-Zangbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahla","family":"Danaii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akbar","family":"Aliasgharzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad Ahmadian","family":"Heris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hojjat-Farsangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"411\u2013426","key":"10.1016\/j.humimm.2024.111229_bb0005","article-title":"Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century","volume":"21","author":"Inhorn","year":"2015","journal-title":"Hum. Reprod. Update"},{"issue":"527\u2013541","key":"10.1016\/j.humimm.2024.111229_bb0010","article-title":"Infertility and miscarriage: common pathways in manifestation and management","volume":"11","author":"Agenor","year":"2015","journal-title":"Womens Health (Lond.)"},{"issue":"18\u201326","key":"10.1016\/j.humimm.2024.111229_bb0015","article-title":"Metabolic syndrome mediates inflammatory and oxidative stress responses in patients with recurrent pregnancy loss","volume":"133","author":"Azizi","year":"2019","journal-title":"J. Reprod. Immunol."},{"issue":"63","key":"10.1016\/j.humimm.2024.111229_bb0020","article-title":"A committee opinion","volume":"99","author":"Definitions of infertility and recurrent pregnancy loss","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.humimm.2024.111229_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040869","article-title":"Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art","volume":"10","author":"Vomstein","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.humimm.2024.111229_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13223-022-00660-8","article-title":"Intravenous immunoglobulins improve live birth rate among women with underlying immune conditions and recurrent pregnancy loss: a systematic review and meta-analysis","volume":"18","author":"Habets","year":"2022","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103759","article-title":"Anti-thyroid antibodies and underlying generalized immunologic aberrations in patients with reproductive failures","volume":"154","author":"Abdolmohammadi-Vahid","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0040","article-title":"Association of thyroid peroxidase antibodies with the rate of first-trimester miscarriage in euthyroid women with unexplained recurrent spontaneous abortion","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.humimm.2024.111229_bb0045","first-page":"373","article-title":"Treatment of recurrent pregnancy loss by levothyroxine in women with high anti-TPO antibody","volume":"10","author":"Mosaddegh","year":"2012","journal-title":"Iran J. Reprod. Med."},{"issue":"e13238","key":"10.1016\/j.humimm.2024.111229_bb0050","article-title":"Effect of antithyroid antibodies on women with recurrent miscarriage: a meta-analysis","volume":"83","author":"Xie","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"issue":"521","key":"10.1016\/j.humimm.2024.111229_bb0055","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Fr\u00f6hlich","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0060","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4049\/jimmunol.2200362","article-title":"Immune-metabolic interactions and T cell tolerance in pregnancy","volume":"209","author":"Moldenhauer","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107118","article-title":"Cytokine imbalance at materno-embryonic interface as a potential immune mechanism for recurrent pregnancy loss","volume":"90","author":"Ali","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2024.111229_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12595","article-title":"The T helper type 17\/regulatory T cell paradigm in pregnancy","volume":"148","author":"Figueiredo","year":"2016","journal-title":"Immunology"},{"issue":"253","key":"10.1016\/j.humimm.2024.111229_bb0075","article-title":"Regulation of the anti-inflammatory cytokines Interleukin-4 and Interleukin-10 during pregnancy","volume":"5","author":"Chatterjee","year":"2014","journal-title":"Front. Immunol."},{"issue":"848\u2013859","key":"10.1016\/j.humimm.2024.111229_bb0080","article-title":"Interferon gamma in successful pregnancies","volume":"80","author":"Murphy","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.humimm.2024.111229_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.placenta.2023.04.004","article-title":"Can circulating levels of transforming growth factor-\u03b21 in early pregnancy serve as a predictive marker of unfavourable outcome?","volume":"137","author":"Dirisipam","year":"2023","journal-title":"Placenta"},{"issue":"233\u2013242","key":"10.1016\/j.humimm.2024.111229_bb0090","article-title":"GATA3: a master of many trades in immune regulation","volume":"35","author":"Wan","year":"2014","journal-title":"Trends Immunol."},{"issue":"689181","key":"10.1016\/j.humimm.2024.111229_bb0095","article-title":"Role of transforming growth factor-\u03b21 in regulating fetal-maternal immune tolerance in Normal and pathological pregnancy","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"issue":"777\u2013789","key":"10.1016\/j.humimm.2024.111229_bb0100","article-title":"T-bet: a bridge between innate and adaptive immunity","volume":"13","author":"Lazarevic","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110326","article-title":"The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL)","volume":"121","author":"Aslanian-kalkhoran","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"e13605","key":"10.1016\/j.humimm.2024.111229_bb0110","article-title":"Efficacy of lymphocyte immunotherapy in the treatment of recurrent pregnancy loss from alloimmunity: a systematic review and meta-analysis","volume":"88","author":"Francisco","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0115","article-title":"T helper (Th) cell profiles in pregnancy and recurrent pregnancy losses: Th1\/Th2\/Th9\/Th17\/Th22\/Tfh cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.30699\/jogcr.9.3.249","article-title":"Comparison of pregnancy outcomes in pregnant women with positive and negative anti-thyroid peroxidase antibody","volume":"9","author":"Shahbazian","year":"2024","journal-title":"J. Obstetrics, Gynecol. Cancer Res."},{"key":"10.1016\/j.humimm.2024.111229_bb0125","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.3390\/ijms21134756","article-title":"Role of human leukocyte antigens at the Feto-maternal Interface in Normal and pathological pregnancy: an update","volume":"21","author":"Tersigni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10044","key":"10.1016\/j.humimm.2024.111229_bb0130","article-title":"Intradermal injection of low dose human regulatory T cells inhibits skin inflammation in a humanized mouse model","volume":"8","author":"Landman","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2024.111229_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/diabetology3010007","article-title":"Novel insights into the immunotherapy-based treatment strategy for autoimmune type 1 diabetes","volume":"3","author":"Rathod","year":"2022","journal-title":"Diabetology"},{"key":"10.1016\/j.humimm.2024.111229_bb0140","first-page":"347","article-title":"Decidual and peripheral blood CD4+ CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases","volume":"10","author":"Sasaki","year":"2004","journal-title":"MHR: Basic Sci. Rep. Med."},{"key":"10.1016\/j.humimm.2024.111229_bb0145","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13104-023-06579-6","article-title":"The association of Treg and Th17 cells development factors and anti-TPO autoantibodies in patients with recurrent pregnancy loss","volume":"16","author":"Niafar","year":"2023","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.humimm.2024.111229_bb0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1530\/EC-13-0012","article-title":"Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case\u2013control study","volume":"2","author":"Lata","year":"2013","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.humimm.2024.111229_bb0155","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.humimm.2024.111229_bb0160","article-title":"The pathogenic role of autoantibodies in recurrent pregnancy loss","volume":"83","author":"D\u2019Ippolito","year":"2020","journal-title":"Am. J. Reprod. Immunol."},{"issue":"299\u2013308","key":"10.1016\/j.humimm.2024.111229_bb0165","article-title":"Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of \u03b2(2) glycoprotein I","volume":"70","author":"Di Simone","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1933719108329095","article-title":"Inflammation and pregnancy","volume":"16","author":"Challis","year":"2009","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.humimm.2024.111229_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101433","article-title":"TPO antibody positivity and adverse pregnancy outcomes","volume":"34","author":"Dhillon-Smith","year":"2020","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.humimm.2024.111229_bb0180","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1515\/mr-2022-0030","article-title":"Understanding recurrent pregnancy loss: recent advances on its etiology, clinical diagnosis, and management","volume":"2","author":"Cao","year":"2022","journal-title":"Med. Rev."},{"key":"10.1016\/j.humimm.2024.111229_bb0185","series-title":"Lymphocyte immunization therapy (LIT) in reproductive failures: n#ew horizons","first-page":"95","article-title":"Controversies about LIT: REMIS study","author":"Raut","year":"2022"},{"key":"10.1016\/j.humimm.2024.111229_bb0190","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.fertnstert.2018.07.004","article-title":"The role of immunotherapy in in vitro fertilization and recurrent pregnancy loss: a systematic review and meta-analysis","volume":"110","author":"Achilli","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.humimm.2024.111229_bb0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(98)12055-X","article-title":"Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial","volume":"354","author":"Ober","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2024.111229_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12958-017-0315-9","article-title":"Low-dose lymphocyte immunotherapy rebalances the peripheral blood Th1\/Th2\/Treg paradigm in patients with unexplained recurrent miscarriage","volume":"15","author":"Liu","year":"2017","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1272\u20131278","key":"10.1016\/j.humimm.2024.111229_bb0205","article-title":"Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion","volume":"9","author":"Liu","year":"2021","journal-title":"Immun Inflamm Dis"},{"issue":"642120","key":"10.1016\/j.humimm.2024.111229_bb0210","article-title":"The effects of LIT and MLR-bf on immune biomarkers and pregnancy outcomes in women with previous early recurrent miscarriage: a retrospective study","volume":"12","author":"Meng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.111229_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13605","article-title":"Efficacy of lymphocyte immunotherapy in the treatment of recurrent pregnancy loss from alloimmunity: a systematic review and meta-analysis","volume":"88","author":"Francisco","year":"2022","journal-title":"Am. J. Reprod. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924004920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924004920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T17:58:16Z","timestamp":1742234296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924004920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0198885924004920"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111229","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradermal lymphocyte therapy: A promising treatment for recurrent pregnancy loss in patients without anti-TPO antibodies","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111229"}}